Investors



SEC Filings

Filing date Form Description Filing Group View
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
View HTML

Copyright Morningstar







© 2018 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Ireland Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
MACRILEN is a trademark of Aeterna Zentaris GmbH, licensed exclusively in the U.S. and Canada to Strongbridge Ireland Limited.
MLR-0010 V13 01/2018

900 Northbrook Drive, Suite 200
Trevose, PA 19053
United States
Phone: +1 610-254-9200
info@strongbridgebio.com

Privacy Statement
Compliance Program